No Data
No Data
Tharimmune Files to Sell 1.44 Million Shares of Common Stock by Selling Shareholders
Express News | Tharimmune: Plan to Report Preliminary Results From Phase 2 Trial in Late 2025
Express News | Tharimmune: Announces Phase 2 Study Plan for TH104 in Patients With Moderate-to-Severe Pruritus Associated With Primary Biliary Cholangitis
Tharimmune Has Entered Into A Securities Purchase Agreement To Raise ~$2.02M Through A Private Placement, To Advance Development Programs
Express News | Tharimmune Inc: Announces $2.02 Mln Private Placement to Advance Development Programs
Tharimmune Announces $2.02 Million Private Placement to Advance Development Programs